Details of the Drug Reposition

General Information of This Drug (ID: DM4UZRE)

• Drug Name: TPIV200 (DM4UZRE)

Information on Drug Reposition of This Drug

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Triple negative breast cancer	DISAMG6N	2C60-2C65	Phase 2	[1]
Ovarian cancer	DISZJHAP	2C73	Phase 2	[2]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)